NEFL and glioblastoma: Based on the GBM-targeting effect of BIOT-NFL-peptide as well as its other profits, our goal in this study was to establish a novel nanosystem that may combine BIOT-NFL-nanofibers with lipid nanocapsules (LNCs) loaded with the anti-microtubule agent (Colchicine).